WikiMD is world's largest health encyclopedia with
28,544 pages, 3,991,366 edits & 34,254,194 views.
Cobimetinib
Information about Cobimetinib
Cobimetinib is a tyrosine kinase receptor inhibitor that is used in combination with vemurafenib as therapy for selected forms of advanced malignant melanoma.
Liver safety of Cobimetinib
The combination of cobimetinib and vemurafenib is commonly associated with serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.
Mechanism of action of Cobimetinib
Cobimetinib (koe" bi me' ti nib) is a small molecule tyrosine kinase receptor inhibitor with potent activity against the mitogen-activated extracellular regulated kinase (MEK), which is an important component of the kinase cascade in the mitogen activated protein kinase (MAPK) pathway (RAS-RAF-MEK-ERK). Components of the MAPK pathways are frequently mutated in patients with malignant melanoma, particularly the RAF isoform BRAF. BRAF-mutations cause a constitutive activation of the MAPK pathways, resulting in unregulated cell growth and proliferation. Inhibition of MEK has been found to be synergistic when combined with specific BRAF inhibitors as therapy of BRAF-mutated cancers. Clinical trials have shown that the addition of cobimetinib with vemurafenib (a specific BRAF-kinase inhibitor) results in improvements in survival in patients with melanoma who harbor the V600 BRAF mutation.
FDA approval information for Cobimetinib
Cobimetinib received accelerated approval for use as combination therapy with vemurafenib in the United States in 2015. Current indications are as combination therapy of metastatic or unresectable melanoma with BRAF V600E or V600K mutations.
Dosage and administration for Cobimetinib
Cobimetinib is available in tablets of 20 mg under the brand name Cotellic. The recommended dose is 60 mg once daily for the first 21 days of each 28-day cycle, continued until disease progression or intolerable toxicity occurs.
Side effects of Cobimetinib
Side effects are common and include diarrhea, rash, photosensitivity, nausea, stomatitis, fever, alopecia and thrombocytopenia. Uncommon, but potentially severe side effects include severe diarrhea leading to dehydration and renal failure, rhabdomyolysis, cardiac toxicity, retinal detachment and embryo-fetal toxicity.
Alphabetic list of antineoplastic agents - 0-9 - A1 - A2 - A3 - A4 - A5 -A6 - B - C - D - E - F - G - H - I - JK - L - M - NO - PQ - R - S - T - UVW - XYZ
Cost and Coupons - Cobimetinib
- GoodRx compare cost & coupons for Cobimetinib
- Find the lowest cost of Cobimetinib
- Search for Coupons for Cobimetinib
Reviews for Cobimetinib
Learn more about Cobimetinib
Latest research (Pubmed)
External links
WikiMD needs you!
This WikiMD article Cobimetinib is a stub.
If you are a healthcare professional familiar with the topic Cobimetinib, or
A subject matter expert or authority on Cobimetinib, you can help us.
About | Mission | Paid editors welcome!
| Cobimetinib is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
